2024-02-05 04:29:21 ET
Summary
- Quantum-Si is about to move from a controlled launch to a full scale commercial launch of its first product.
- It will be a groundbreaking device, a desktop Proteome sequencer at a fraction of the price of competing technology.
- If the product is successful, QSI stock is likely significantly undervalued.
Quantum-Si ( QSI ) will launch the first low-cost desktop device capable of sequencing proteins from small samples without expensive equipment or specialist operators in the first quarter 2024. They have a first-mover advantage, an unmet need, and a developing scientific reputation.
If the launch goes well and the product is well received, QSI looks significantly undervalued and represents an excellent risk/reward investment....
Read the full article on Seeking Alpha
For further details see:
Quantum-Si: Commercial Lift Imminent